IL-23 and IL-17 in tuberculosis

Cytokine

Volumn 41, Issue 2, 2008, Pages 79-83

  Khader, Shabaana A ^a   Cooper, Andrea M ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

Cytokines; Inflammation; Tuberculosis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 23;

BACTERIAL GROWTH; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LUNG PARENCHYMA; LUNG TUBERCULOSIS; MEMORY CELL; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PRIMARY INFECTION; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

BCG VACCINE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-23; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, HELPER-INDUCER; TUBERCULOSIS; VACCINATION;

ANIMALIA; BACTERIA (MICROORGANISMS); MYCOBACTERIUM TUBERCULOSIS;

EID: 38949133035     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.11.022     Document Type: Review

References (52)

1. Chackerian A., Alt J., Perera T., Dascher C., and Behar S.M. Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun 70 (2002) 4501-4509
2. Khader S., Bell G., Pearl J., Fountain J., Rangel-Moreno J., Cilley G., et al. IL-23 and IL-17 in establishment of protective pulmonary CD4+ T cell responses upon vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8 (2007) 369-377
3. Mogues T., Goodrich M.E., Ryan L., LaCourse R., and North R.J. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 193 (2001) 271-280
4. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., and Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178 (1993) 2243-2247
5. Flynn J.L., Goldstein M.M., Chan J., Triebold K.J., Pfeffer K., Lowenstein C.J., et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2 (1995) 561-572
6. Cooper A.M., Kipnis A., Turner J., Magram J., Ferrante J., and Orme I.M. Mice lacking bioactive IL-12 can generate protective, antigen-specific cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present. J Immunol 168 (2002) 1322-1327
7. Cooper A.M., Pearl J.E., Brooks J.V., Ehlers S., and Orme I.M. Expression of nitric oxide synthase 2 gene is not essential for early control of Mycobacterium tuberculosis in the murine lung. Infect Immun 68 (2000) 6879-6882
8. Turner J., Dobos K., Keen M., Frank A., Ehlers S., Orme I., et al. A limited antigen-specific cellular response is sufficient for the early control of Mycobacterium tuberculosis in the lung but is insufficient for long-term survival. Infect Immun 72 (2004) 3759-3768
9. Rhoades E.R., Frank A.A., and Orme I.M. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. Tuberc Lung Dis 78 (1997) 57-66
10. Winslow G., Roberts A., Blackman M., and Woodland D. Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse. J Immunol 170 (2003) 2046-2052
11. Flynn J., and Chan J. Tuberculosis: latency and reactivation. Infect Immun 69 (2001) 4195-4201
12. Khader S., Pearl J., Sakamoto K., Gilmartin L., Bell G., Jelley-Gibbs D., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175 (2005) 788-795
13. Lockhart E., Green A., and Flynn J. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177 (2006) 4662-4669
14. Wozniak T., Ryan A., Triccas J., and Britton W. Plasmid interleukin-23 (IL-23), but not plasmid IL-27, enhances the protective efficacy of a DNA vaccine against Mycobacterium tuberculosis infection. Infect Immun 74 (2006) 557-565
15. Cruz A., Khader S., Torrado E., Fraga A., Pearl J., Pedrosa J., et al. CE:IFN-g regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection1. J Immunol 177 (2006) 1416-1420
16. Stockinger B., and Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immun 19 (2007) 281-286
17. Mangan P., Harrington L., O'Quinn D., Helms W., Bullard D., Elson C., et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 (2006) 231-234
18. Veldhoen M., Hocking R., Atkins C., Locksley R., and Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24 (2006) 179-189
19. Chen Z., Tato C., Muul L., Laurence A., and O'Shea J. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56 (2007) 2936-2946
20. Wilson N., Boniface K., Chan J., McKenzie B., Blumenschein W., Mattson J., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
21. Chackerian A., Chen S., Brodie S., Mattson J., McClanahan T., Kastelein R., et al. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect Immun 74 (2006) 6092-6099
22. Happel K., Lockhart E., Mason C., Porretta E., Keoshkerian E., Odden A., et al. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs. Infect Immun 73 (2005) 5782-5788
23. Wozniak T., Ryan A., and Britton W. Interleukin-23 restores immunity to Mycobacterium tuberculosis infection in IL-12p40-deficient mice and is not required for the development of IL-17-secreting T cell responses. J Immunol 177 (2006) 8684-8692
24. Umemura M., Yahagi A., Hamada S., Begum M., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis Bacille Calmette-Guerin infection. J Immunol 178 (2007) 3786-3796
25. D'Souza C.D., Cooper A.M., Frank A.A., Mazzaccaro R.J., Bloom B.R., and Orme I.M. An anti-inflammatory role for gd T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J Immunol 158 (1997) 1217-1221
26. Michel M., Keller A., Paget C., Fujio M., Trottein F., Savage P., et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J Exp Med 204 (2007) 995-1001
27. Colditz G., Brewer T., Berkey C., Wilson M., Burdick E., Fineberg H., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 (1994) 698-702
28. Cooper A.M., Callahan J.E., Keen M., Belisle J.T., and Orme I.M. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tuberc Lung Dis 78 (1997) 67-73
29. Jung Y., Ryan L., Lacourse R., and North R. Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 201 (2005) 1915-1924
30. Stumhofer J., Laurence A., Wilson E., Huang E., Tato C., Johnson L., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 7 (2006) 937-945
31. Batten M., Li J., Yi S., Kljavin N., Danilenko D., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7 (2006) 929-936
32. Sergejeva S., Ivanov S., Lotvall J., and Linden A. IL-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. Am J Resp Cell Mol Biol 33 (2005) 248-253
33. Kolls J., and Linden A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
34. Miyamoto M., Prause O., Sjostrand M., Laan M., Lotvall J., and Linden A. Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways. J Immunol 170 (2003) 4665-4672
35. Stark M., Huo Y., Burcin T., Morris M., Olson T., and Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 22 (2005) 285-294
36. Shen F., Hu Z., Goswami J., and Gaffen S. Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281 (2006) 24138-24148
37. Dragon S, Saffar A, Shan L, Gounni A. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. Mol Immunol 2007. epub.
38. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., et al. The IL-23/IL-17 pathway promotes inflammation and impairs antifungal immune resistance. Eur J Immunol 37 (2007) 2695-2706
39. Khader S, Solache A, Pearl J, Fountain J, Rangel-Moreno J, Martino C, et al. IL-27R on CD4 T cells limits the protective response to Mycobacterium tuberculosis but not as a result of limiting the generation of Th17 cells. Personal communication.
40. Holscher C., Holscher A., Ruckerl D., Yoshimoto T., Yoshida H., Mak T., et al. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J Immunol 174 (2005) 3534-3544
41. Pearl J.E., Shabaana A.K., Solache A., Gilmartin L., Ghilardi N., deSauvage F., et al. IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice. J Immunol 173 (2004) 7490-7496
42. Akahoshi M., Nakashima H., Miyake K., Inoue Y., Shimizu S., Tanaka Y., et al. Influence of interleukin-12 receptor b1 polymorphisms on tuberculosis. Hum Genet 112 (2003) 237-243
43. Tso H.W., Lau Y.L., Tam C.M., Wong H.S., and Chiang A.K. Associations between IL12b polymorphisms and tuberculosis in the Hong Kong chinese population. J Inf Dis 190 (2004) 913-919
44. Doffinger R., Dupius S., Picard C., Fieschi C., Feinberg J., Barcenas-Morales G., et al. Inherited disorders of IL-12 and IFN-G mediated immunity: a molecular genetics update. Mol Immunol 38 (2001) 903-909
45. Fieschi C., Bosticardo M., de Beaucoudrey L., Boisson-Dupuis S., Feinberg J., Santos O.F., et al. A novel form of complete IL-12/IL-23 receptor b1-deficiency with cell surface-expressed non-functional receptors. Blood 104 (2004) 2095-2101
46. Sakai T., Matsuoka M., Aoki M., Nosaka K., and Mitsuya H. Missense mutation of the interleukin-12 receptor B1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 97 (2001) 2688-2694
47. Lichtenauer-Kaligis E.G.R., de Boer T., Verreck F.A.W., van Voorden S., Hoeve M.A., van de Vosse E., et al. Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor B1 deficient patients and evidence for the existence of partial IL-12 receptor B1 deficiency. Eur J Immunol 33 (2003) 59-69
48. Filipe-Santos O., Bustamante J., Chapgier A., Vogt G., de Beaucoudrey L., Feinberg J., et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol 18 (2006) 347-361
49. Hoeve M., de Boer T., Langenberg D., Sanal O., Verreck F., and Ottenhoff T. IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency. Eur J Immunol 33 (2003) 3393-3397
50. Hoeve M., Savage N., de Boer T., Langenberg D., de Waal Malefyt R., Ottenhoff T., et al. Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells. Eur J Immunol 36 (2006) 661-670
51. Duerr R., Taylor K., Brant S., Rioux J., Silverberg M., Daly M., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
52. Feller M., Huwiler K., Stephan R., Altpeter E., Shang A., Furrer H., et al. Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. Lancet Inf Dis 7 (2007) 607-613